489 related articles for article (PubMed ID: 17532494)
21. Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy: clinical and translational issues.
Nichol AM; Warde P; Bristow RG
Cancer; 2005 Sep; 104(5):891-905. PubMed ID: 16007687
[TBL] [Abstract][Full Text] [Related]
22. Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?
Roach M
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():26-8. PubMed ID: 18167004
[TBL] [Abstract][Full Text] [Related]
23. Sequential treatment for recurrent localized prostate cancer.
Van Der Poel HG; Moonen L; Horenblas S
J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
[TBL] [Abstract][Full Text] [Related]
24. A systematic overview of radiation therapy effects in prostate cancer.
Nilsson S; Norlén BJ; Widmark A
Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
[TBL] [Abstract][Full Text] [Related]
25. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in Taiwan.
Chen YC; Chuang CK; Hsieh ML; Chen WC; Fan KH; Yeh CY; Lee CC; Hong JH
Urology; 2007 Jul; 70(1):101-5. PubMed ID: 17656217
[TBL] [Abstract][Full Text] [Related]
26. [The treatment options for localized prostate cancer].
Livne PM
Harefuah; 2006 Jan; 145(1):36-7, 77. PubMed ID: 16450723
[TBL] [Abstract][Full Text] [Related]
27. Failure to achieve a PSA level Mitchell DM; McAleese J; Park RM; Stewart DP; Stranex S; Eakin RL; Houston RF; O'Sullivan JM
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1467-71. PubMed ID: 17689886
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
Macdonald OK; D'Amico AV; Sadetsky N; Shrieve DC; Carroll PR
Urology; 2007 Jul; 70(1):106-10. PubMed ID: 17656218
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?
Ganswindt U; Stenzl A; Bamberg M; Belka C
Eur Urol; 2008 Sep; 54(3):528-42. PubMed ID: 18602742
[TBL] [Abstract][Full Text] [Related]
30. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
[TBL] [Abstract][Full Text] [Related]
31. [Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: immediate postoperative or salvage?].
Pasquier D; Kouto H; Ballereau C
Prog Urol; 2009 Jul; 19(7):447-56. PubMed ID: 19559374
[TBL] [Abstract][Full Text] [Related]
32. Definitive radiotherapy for prostate cancer.
Mendenhall WM; Henderson RH; Mendenhall NP
Am J Clin Oncol; 2008 Oct; 31(5):496-503. PubMed ID: 18838889
[TBL] [Abstract][Full Text] [Related]
33. The role of high-dose rate brachytherapy in locally advanced prostate cancer.
Vicini FA; Vargas C; Edmundson G; Kestin L; Martinez A
Semin Radiat Oncol; 2003 Apr; 13(2):98-108. PubMed ID: 12728439
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
Dattoli M; Wallner K; True L; Cash J; Sorace R
Cancer; 2007 Aug; 110(3):551-5. PubMed ID: 17577217
[TBL] [Abstract][Full Text] [Related]
35. [Prostate cancer treatments in Belgium].
Kaitouni MI; Roumeguère T
Rev Med Brux; 2009 Sep; 30(4):270-8. PubMed ID: 19899373
[TBL] [Abstract][Full Text] [Related]
36. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188
[TBL] [Abstract][Full Text] [Related]
37. Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
Liauw SL; Fricano J; Correa D; Weichselbaum RR; Jani AB
Cancer; 2009 Apr; 115(8):1784-90. PubMed ID: 19208426
[TBL] [Abstract][Full Text] [Related]
38. The management of high risk prostate cancer.
Akduman B; Crawford ED
J Urol; 2003 Jun; 169(6):1993-8. PubMed ID: 12771704
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy.
Kibel AS; Nelson JB
Prostate Cancer Prostatic Dis; 2007; 10(2):119-26. PubMed ID: 17310261
[TBL] [Abstract][Full Text] [Related]
40. [Three dimensional conformal radiotherapy (3D-CRT) for localized prostate cancer under field adjustment with implanted gold markers: early clinical outcome].
Taketa S; Shimada O; Tsukuda F; Inui M; Kuwata Y; Kakehi Y; Mitani M; Takashima H
Hinyokika Kiyo; 2004 Sep; 50(9):611-6. PubMed ID: 15518125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
